Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Feb;31(2):183–186. doi: 10.1128/aac.31.2.183

Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.

A M Jokipii, L Jokipii
PMCID: PMC174688  PMID: 3566248

Abstract

Broth dilution MICs of metronidazole against 38 strains of Clostridium difficile (0.13 microgram/ml) and 11 strains of Peptostreptococcus anaerobius (0.11 microgram/ml) were lower than those of tinidazole (0.16 and 0.17 microgram/ml, respectively). As molar concentrations the nitroimidazoles were equally active. The MICs of the two drugs correlated positively, and the relative activity of tinidazole increased with decreasing susceptibility of both species.

Full text

PDF
183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. G., Chang T., Taylor N. S., Onderdonk A. B. Colitis induced by Clostridium difficile. Rev Infect Dis. 1979 Mar-Apr;1(2):370–378. doi: 10.1093/clinids/1.2.370. [DOI] [PubMed] [Google Scholar]
  2. Bolton R. P. Clostridium difficile-associated colitis after neomycin treated with metronidazole. Br Med J. 1979 Dec 8;2(6203):1479–1480. doi: 10.1136/bmj.2.6203.1479-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brook I., Walker R. I. Pathogenicity of anaerobic gram-positive cocci. Infect Immun. 1984 Aug;45(2):320–324. doi: 10.1128/iai.45.2.320-324.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brook I., Walker R. I. The role of encapsulation in the pathogenesis of anaerobic gram-positive cocci. Can J Microbiol. 1985 Feb;31(2):176–180. doi: 10.1139/m85-033. [DOI] [PubMed] [Google Scholar]
  5. Cherry R. D., Portnoy D., Jabbari M., Daly D. S., Kinnear D. G., Goresky C. A. Metronidazole: an alternate therapy for antibiotic-associated colitis. Gastroenterology. 1982 May;82(5 Pt 1):849–851. [PubMed] [Google Scholar]
  6. Chow A. W., Patten V., Guze L. B. Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli. J Infect Dis. 1975 Feb;131(2):182–185. doi: 10.1093/infdis/131.2.182. [DOI] [PubMed] [Google Scholar]
  7. Dinh H. T., Kernbaum S., Frottier J. Treatment of antibiotic-induced colitis by metronidazole. Lancet. 1978 Feb 11;1(8059):338–339. doi: 10.1016/s0140-6736(78)90119-8. [DOI] [PubMed] [Google Scholar]
  8. Dornbusch K., Nord C. E. In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol. 1974;160(4):265–267. doi: 10.1007/BF02121441. [DOI] [PubMed] [Google Scholar]
  9. Edwards D. I., Dye M., Carne H. The selective toxicity of antimicrobial nitroheterocyclic drugs. J Gen Microbiol. 1973 May;76(1):135–145. doi: 10.1099/00221287-76-1-135. [DOI] [PubMed] [Google Scholar]
  10. Hill G. B., Ayers O. M. Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections. Antimicrob Agents Chemother. 1985 Mar;27(3):324–331. doi: 10.1128/aac.27.3.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johnson T. A., Tabbut B. R., Page C. O. Treatment of antibiotic-associated pseudomembranous colitis with metronidazole. Am J Hosp Pharm. 1981 Jul;38(7):1034–1035. [PubMed] [Google Scholar]
  12. Jokipii A. M., Jokipii L. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria. Chemotherapy. 1977;23(1):25–31. doi: 10.1159/000221967. [DOI] [PubMed] [Google Scholar]
  13. Jokipii A. M., Jokipii L., Vesterinen E., Purola E., Vartiainen E., Paavonen J. Volatile fatty acid findings in vaginal fluid compared with symptoms, signs, other laboratory results, and susceptibility to tinidazole of malodorous vaginal discharges. Genitourin Med. 1986 Apr;62(2):102–106. doi: 10.1136/sti.62.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jokipii L., Jokipii A. M. Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro. J Antimicrob Chemother. 1977 Nov;3(6):571–577. doi: 10.1093/jac/3.6.571. [DOI] [PubMed] [Google Scholar]
  15. Jokipii L., Jokipii A. M. Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group. Antimicrob Agents Chemother. 1985 Oct;28(4):561–564. doi: 10.1128/aac.28.4.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jokipii L., Jokipii A. M. In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole. J Infect Dis. 1980 Mar;141(3):317–325. doi: 10.1093/infdis/141.3.317. [DOI] [PubMed] [Google Scholar]
  17. Jokipii L., Jokipii A. M. Single-dose metronidazole and tinidazole as therapy for giardiasis: success rates, side effects, and drug absorption and elimination. J Infect Dis. 1979 Dec;140(6):984–988. doi: 10.1093/infdis/140.6.984. [DOI] [PubMed] [Google Scholar]
  18. Malcolm A. J. Pseudomembranous colitis in a colostomy. Br Med J. 1978 Aug 12;2(6135):479–479. doi: 10.1136/bmj.2.6135.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matuchansky C., Aries J., Maire P. Metronidazole for antibiotic-associated pseudomembraneous colitis. Lancet. 1978 Sep 9;2(8089):580–581. doi: 10.1016/s0140-6736(78)92921-5. [DOI] [PubMed] [Google Scholar]
  20. Nicolopoulos N. G., Stathapoulos E. N., Douzinas E. E., Vassilakis J. S. Pseudomembranous colitis. Treatment by metronidazole. Hepatogastroenterology. 1981 Apr;28(2):120–122. [PubMed] [Google Scholar]
  21. Nord C. E. Microbiological properties of tinidazole: spectrum, activity and ecological considerations. J Antimicrob Chemother. 1982 Aug;10 (Suppl A):35–42. doi: 10.1093/jac/10.suppl_a.35. [DOI] [PubMed] [Google Scholar]
  22. Pashby N. L., Bolton R. P., Sherriff R. J. Oral metronidazole in Clostridium difficile colitis. Br Med J. 1979 Jun 16;1(6178):1605–1606. doi: 10.1136/bmj.1.6178.1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Reynolds A. V., Hamilton-Miller J. M., Brumfitt W. A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli. J Clin Pathol. 1975 Oct;28(10):775–778. doi: 10.1136/jcp.28.10.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Reynolds A. V. The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinity. J Antimicrob Chemother. 1981 Aug;8(2):91–99. doi: 10.1093/jac/8.2.91. [DOI] [PubMed] [Google Scholar]
  25. Teasley D. G., Gerding D. N., Olson M. M., Peterson L. R., Gebhard R. L., Schwartz M. J., Lee J. T., Jr Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet. 1983 Nov 5;2(8358):1043–1046. doi: 10.1016/s0140-6736(83)91036-x. [DOI] [PubMed] [Google Scholar]
  26. Werner H., Schädler G., Krasemann C. In vitro activity of azlocillin, metronidazole and its hydroxy metabolite against anaerobes. Bacteriostatic synergism studies. Arzneimittelforschung. 1983;33(4):574–577. [PubMed] [Google Scholar]
  27. Wust J. Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods. Antimicrob Agents Chemother. 1977 Apr;11(4):631–637. doi: 10.1128/aac.11.4.631. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES